Last reviewed · How we verify
Balloon-occluded Retrograde Transvenous Obliteration Versus Endoscopic Tissue Glue Injection in the Prevention of Recurrent Gastric Variceal Bleeding
The goal of this randomized controlled trial is to compare the rebleeding rate in cirhotic patients with gastric variceal bleeding receiving balloon-occluded retrograde transvenous obliteration and endoscopic tissue glue injection. The main questions it aims to answer are: * Recurrent gastric variceal bleeding * Further decompensation of liver cirrhosis Participants will receive balloon-occluded retrograde transvenous obliteration and endoscopic tissue glue injection. Researchers will compare balloon-occluded retrograde transvenous obliteration and endoscopic tissue glue injection to see if the rebleeding rate associated with balloon-occluded retrograde transvenous obliteration is lower than that associated with endoscopic tissue glue injection.
Details
| Lead sponsor | Kaohsiung Veterans General Hospital. |
|---|---|
| Phase | Phase 3 |
| Status | UNKNOWN |
| Enrolment | 68 |
| Start date | 2018-06-28 |
| Completion | 2025-06 |
Conditions
- Gastric Varices Bleeding
- Liver Decompensation
Interventions
- Sodium tetradecyl sulfate
- Cyanoacrylate
Primary outcomes
- recurrent gastric variceal bleeding — From date of randomization until the date of first documented recurrent gastric variceal bleeding or date of death from any cause, whichever comes first, assessed up to 100 months
recurrent gastric variceal bleeding after interventions - further liver decompensation — From date of randomization until the date of first documented further liver decompensation or date of death from any cause, whichever comes first, assessed up to 100 months
further liver decompensation after intervensions
Countries
Taiwan